The U.S. landscape of biotechnology and pharmaceutical research is marked by clusters of innovation, investment, and scientific output. For 2024, several regions stand out due to their exceptional contributions to the biopharma sectors, from Boston’s academic might to San Diego’s venture capital inf
September 27, 2024
Multiply Labs and Legend Biotech have announced a strategic collaboration aimed at transforming cell therapy production through advanced robotics. This partnership between Multiply Labs, renowned for its innovative automation systems, and Legend Biotech, celebrated for its role in developing the
September 25, 2024
The ongoing evolution of digital technologies offers the potential to profoundly transform the Australian healthcare system, and this promise is becoming increasingly evident. Published by Cosmos, the article explores the significant advancements in artificial intelligence (AI), digital twins, and
September 11, 2024
Agilent Technologies Inc. has unveiled its new Biopharma CDx Services Lab (BCSL) in Carpinteria, California, marking a significant stride in the field of precision medicine. This state-of-the-art facility is poised to revolutionize the drug development process by streamlining the journey from early
September 10, 2024
NImmune Biopharma has recently announced a strategic partnership with BioTherapeutics aimed at accelerating the development of precision medicines for inflammation and immunology. The collaboration is designed to bolster NImmune’s capabilities by integrating BioTherapeutics’ extensive preclinical se
September 6, 2024
The biopharmaceutical industry, or biopharma, stands at the forefront of medicine and biotechnology, bringing revolutionary advancements to patient care and medical treatments. Biopharma focuses on developing drugs from biological sources, offering a wide range of therapies that are changing lives.
August 16, 2024
